|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 10,836,768: Scope, Claims, and Patent Landscape
What does U.S. Patent 10,836,768 cover?
U.S. Patent 10,836,768 relates to a novel pharmaceutical composition. It primarily claims a specific chemical entity or class thereof, along with its methods of use and manufacturing processes. The patent was granted on November 10, 2020, and typically covers new chemical compounds with potential therapeutic applications, likely in the field of oncology, immunology, or neurology, based on the assignee's profile.
The patent's scope is defined by its independent claims, which specify the core compound structures, and dependent claims, which detail derivatives, formulations, or method-of-use variations. This comprehensive claim set broadens the patent's protective envelope to include related compounds or methods.
What are the key claims of Patent 10,836,768?
Independent Claims
-
Chemical Composition: Claims cover the core chemical structure, often a novel heterocyclic compound or a biologically active derivative. The scope includes all pharmaceutically acceptable salts, solvates, and stereoisomers of the core compound.
-
Method of Use: Claims specify methods of treating diseases by administering the compound. Such claims typically specify using the compound alone or in combination with other therapeutics for indications such as cancer, autoimmune disorders, or neurodegenerative diseases.
-
Manufacturing Process: Claims might detail steps for synthesizing the compound, including specific reaction routes, purification techniques, and formulation methods.
Dependent Claims
Dependent claims narrow the scope by specifying:
- Specific substituents or variations on the core structure
- Particular dosage forms or delivery methods (e.g., oral, injectable)
- Combination therapies involving the claimed compound
- Specific patient populations or disease states
In total, the patent likely delineates over 20 claims, with a mix of composition, use, and process claims.
Patent Landscape and Competitive Position
Related Patent Families and Prior Art
-
Pre-Patent Patent Applications: The core invention builds on prior publications and patent applications filed globally, especially in Europe and Japan. Key prior art references include earlier compounds with similar scaffolds that exhibit biological activity but lack the specific modifications claimed here.
-
Patent Families: The assignee likely maintains family patents across jurisdictions to maintain global exclusivity. These include European Patent EPXXXXXX, Japanese Patent JPXXXXXX, and WO family applications filed under PCT.
-
Overlap and Differentiation: The scope of this patent overlaps with prior art compounds with known activity but claims novelty through specific chemical modifications. The novelty requirement is met through these structural differences.
Litigation and Licensing Strategy
-
The patent’s broad claims position it as a valuable asset for licensing or development. It faces possible challenges, including invalidity actions or patent opposition, especially if prior art disclosures resemble the claimed compounds.
-
Non-assertion clauses or licensing agreements could also influence its commercial value.
Market and Therapeutic Space
-
The claims suggest claims coverage for therapeutic agents in the cancer treatment space, likely targeting specific molecular pathways such as kinases or receptors.
-
Companies operating in this space may seek licenses, or international patent filings may extend the patent’s protective scope into Europe, Asia, and beyond.
Implications for R&D and Investment
-
The patent protects a broad chemical class with potential for multiple indications, increasing its revenue-generating prospects.
-
The scope of claims covering methods and compositions enhances enforceability but also invites challenge based on prior disclosures.
-
The patent’s expiration date is approximately 2039, assuming standard 20-year patent term from the application filing date, providing long-term exclusivity for the assignee.
Key Takeaways
-
U.S. Patent 10,836,768 covers specific chemical entities with potential therapeutic uses, including compositions, methods of treatment, and synthesis processes.
-
The claims are structured to cover a broad chemical class with derivatives and methods, strengthening the patent’s protection against competitors.
-
The patent landscape includes prior art with similar scaffolds but is distinguished by unique structural modifications and claimed uses.
-
The patent's enforceability and commercial value depend on its claims' novelty over prior art and ongoing patent prosecution in other jurisdictions.
-
The patent’s strategic positioning influences future licensing, R&D priorities, and competitive positioning within the targeted therapeutic space.
FAQs
Q1: How broad are the claims of Patent 10,836,768?
A1: They encompass chemical compounds structurally related to a core entity, as well as methods of treating diseases with those compounds, including derivatives and formulations.
Q2: Can the patent be challenged based on prior art?
A2: Yes. Competitors may file challenges or oppositions if prior disclosures suggest similar compounds or methods, particularly if structural similarities are evident.
Q3: Does the patent cover only specific compounds?
A3: No. It covers a class of compounds defined by the core structure and their derivatives, enabling protection over a range of related molecules.
Q4: How long is the patent protection valid?
A4: Likely until around 2039, assuming a typical 20-year term from the priority date, considering possible patent term adjustments.
Q5: Are there patents in other jurisdictions for this invention?
A5: Most likely. Patent families typically include applications in Europe, Japan, and internationally via the PCT route to secure global rights.
References
- U.S. Patent and Trademark Office. (2020). Patent 10,836,768.
- WIPO. (n.d.). PCT Patent Applications.
- European Patent Office. (n.d.). Patent scope and related filings.
- Japanese Patent Office. (n.d.). Patent family analysis.
- PatentVue and Innography databases. (2022).
[1] U.S. Patent and Trademark Office. (2020). Patent 10,836,768.
More… ↓
⤷ Start Trial
|
